Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus- pertussis vaccine (DTP-Hib), in Indonesian infants

Vaccine

Volumn 24, Issue 11, 2006, Pages 1776-1785

  Punjabi, Narain H ^a   Richie, Emily L ^a   Simanjuntak, Cyrus H ^b   Harjanto, Sri Juliani ^a   Wangsasaputra, Ferry ^a   Arjoso, Sumarjati ^b   Rofiq, Ainur ^b   Prijanto, Mulyati ^b   Julitasari, ^c   Yela, Ursula ^d   Herzog, Christian ^d   Cryz, Stanley J ^e  

^a US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

^b NATIONAL INSTITUTE OF HEALTH RESEARCH AND DEVELOPMENT   (Indonesia)

^c MINISTRY OF HEALTH   (Indonesia)

^d Berna Biotech AG   (Switzerland)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

DTP Hib; Haemophilus influenzae type b; Lower dose

Indexed keywords

ANTIBODY; ANTIGEN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PHOSPHATE; POLYRIBOSYLPHOSPHATE; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; COUGHING; CRYING; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG CONJUGATION; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG SAFETY; DYSPNEA; FEBRILE CONVULSION; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INDONESIA; INFANT; INJECTION SITE ABSCESS; INJECTION SITE INDURATION; INJECTION SITE REACTION; IRRITABILITY; LOW DRUG DOSE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SIDE EFFECT; VACCINATION;

ANTIBODIES, BACTERIAL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DOUBLE-BLIND METHOD; FEVER; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION, SECONDARY; INDONESIA; INFANT; PENTOSEPHOSPHATES; POLYSACCHARIDES, BACTERIAL; TETANUS TOXOID; VACCINES, CONJUGATE;

EID: 32544457374     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.10.023     Document Type: Article

References (49)

1. F. Shann, and M.C. Steinhoff Vaccines for children in rich and poor countries Lancet 354 1999 7 11
2. S.C. Arya Human immunization in developing countries: practical and theoritical problems and prospects Vaccine 12 1994 1423 1435
3. K.J. Bart, and K.F.Y.C. Lin Vaccine-preventable disease and immunization in the developing world Ped Clin N Am 37 1990 735 755
4. H. Peltola Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates Clin Microbiol Rev 13 2000 302 317
5. W.G. Adams, K.A. Deaver, S.L. Cochi, B.D. Plikaytis, E.R. Zell, and M. Stat Decline of childhood Haemophilus influenzae type b (Hib) disease since introduction of vaccination JAMA 269 1993 246 248
6. H. Peltola Haemophilus influenzae type b disease and vaccination in Europe: lesson learned Pediatr Infect Dis J 17 1998 S126 S132
7. D. Wenger Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccine in the United States and Canada Pediatr Infect Dis J 17 1998 S132 S136
8. J. Eskola, A.K. Takala, H. Katyhty, H. Peltola, and P.H. Makela Experience in Findland with Haemophilus influenzae type b vaccines Vaccine 9 1993 S514 S516
9. 197(HbOC) conjugate vaccine Pediatr Infect Dis J 12 1993 478 484
10. R.S. Munson Jr., M.H. Kabeer, A.A. Lenoir, and D.M. Granoff Epidemiology and prospects for prevention of disease due to Haemophilus influenzae in developing countries Rev Infect Dis 11 S3 1989 S588 S597
11. H. Peltola Spectrum and burden of severe Haemophilus influenzae type b disease in Asia Bull WHO 77 1999 878 887
12. ML. Punjabi Typhoid fever: a continuing health problem for pediatric population in developing countries J.T. Ou C.H. Chiu C.S. Chu Typhoid fever and other salmonellosis 2001 Jeou Chou Book Co. Taipei, ROC 25 49
13. D.M. Salisbury Summary statements: The First International Conference on Haemophilus influenzae type b in Asia Pediatr Infect Dis J 17 1998 S93 S95
14. K. Mulholland, S. Hilton, R. Adegbola, S. Usen, A. Oparaugo, and C. Omosigho Randomized trial of Haemophilus influenzae type b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants Lancet 349 1997 1191 1197
15. R. Dagan, D. Fraser, Z. Greif, N. Keller, M. Kaufstein, and G. Shasberg Isreali pediatric bacteremia and meningitis group. A nationwide prospective surveillance study in Israel to document pediatric invasive infections, with an emphasis on Haemophilus influenzae type b infections Pediatr Infect Dis J 17 1998 S198 S203
16. M. Miller An assessment of the value of Haemophilus influenzae type b conjugate vaccine in Asia Pediatr Infect Dis J 17 1998 S152 S159
17. 197 and tetanus toxoid conjugated Haemophilias influenzae type b vaccines Vaccine 23 2004 802 806
18. ™) with three investigational, liquid formulations using lower doses of Hib-CRM197 conjugate Vaccine 23 2005 1715 1719
19. E. Richie, N.H. Punjabi, S.J. Harjanto, F. Wangsasaputra, M. Sukandar, and M. Suptriatman Safety and immunogenicity of combined diphtheria-tetanus- pertussis (whole cell and acellular)-Haemophilus influenzae type b conjugate vaccine administered to Indonesian children Vaccine 17 1999 1384 1393
20. C.H. Panpitpat, U. Thisyakorn, T. Chotpitayasunondh, E. Furer, J.U. Que, and T. Hasler Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b PRP-tetanus toxoid conjugate vaccine Bull WHO 78 2000 364 371
21. S.L. Plotkin, and S.A. Plotkin Short history of vaccination S.A. Plotkin W.A. Orenstein Vaccine 3rd ed. 1999 WB Saunders Philadelphia 1 12
22. NIAID International Centers for Tropical Disease Research. Death and disease in the majority world. Key to recognition and prevention. Vaccine for tropical diseases. Report of the second annual meeting, April 28-30, 1993. p. 13-24.
23. J.D. Ernst Toward the development of antibacterial vaccines: report of a symposium and workshop Clin Infect Dis 29 1999 1295 1302
24. A. Marchant, and M. Newport Prevention of infectious diseases by neonatal and early infantile immunization: prospects for the new millenium Curr Opin Infect Dis 13 2000 241 246
25. M.A. Kane Commentary: public perception and the safety of immunization Vaccine 16 1998 S73 S75
26. R. Lagos, M.T. Valenzuela, O.S. Levine, G.A. Losonsky, A. Erazo, and S.S. Wasserman Economisation of vaccination against Haemophilus influenzae type b: a randomized trial of immunogenicity of fractional-dose and two-dose regimens Lancet 351 1998 1472 1476
27. Central Bureau of Statistics and Indonesian Ministry of Health. Demographic Health Surveys, Indonesian EVIR. September 1998. p. 183-221.
28. J.I. Ward, and Zangwill Haemophilus influenzae vaccines S.A. Plotkin W.A. Orenstein Vaccine 3rd ed. 1999 WB Saunders Philadelphia 183 221
29. B. Fritzell, and S.A. Plotkin Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine J Pediatr 121 1992 355 362
30. Pickering LK, Peter G, Baker CJ, Gerber Ma, MacDonald NA, Orenstein WA, et al. Haemophilus influenzae infections. American Academy of Pediatrics. In: 2000 Red book: report of the Committee on Infectious Diseases, 25th ed. 2000. p. 262-272.
31. N.T. Begg, E.M. Miller, C.K. Fairley, H.M. Chapel, H. Griffiths, and P.A. Waight Antibody responses and symptoms after DTP and either tetanus or diphtheria Haemophilus influenzae type B conjugate vaccines given for primary immunization by separate or mixed injection Vaccine 134 1995 1547 1550
32. C. Ferreccio, J. Clemens, A. Avenando, I. Horwitz, C. Flores, and L. Avila The clinical and immunological responses of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age Pediatr Infect Dis J 10 1991 764 771
33. B.A. Claesson, R. Schneerson, T. Lagergard, B. Trollfors, J. Taranger, and J. Johansson Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age Pediatr Infect Dis J 10 1991 560 564
34. T. Chotpitayasunondh, C. Panpitpat, U. Thisyakorn, E. Furer, J.U. Que, and T. Hasler Safety and immunogenicity of a Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants Southeast Asian J Trop Med Public Health 28 1997 91 98
35. D.D. Decker, and K.M. Edwards Haemophilus influenzae type b vaccine: history, choice and comparisons Pediatr Infect Dis J 17 1998 S113 S116
36. C.L. Cody, L.J. Baraff, J.D. Cherry, S.M. Marcy, and C.R. Manclark Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children Pediatrics 68 1981 650 660
37. K. Edwards, M.D. Decker, and E.A. Mortimer Jr. Pertussis vaccine S.A. Plotkin W.A. Orenstein Vaccine 3rd ed. 1999 WB Saunders Philadelphia 293 344
38. K.M. Edwards, and M.D. Decker Acellular pertussis vaccines for infants New Engl J Med 334 1996 391 392
39. E.J. Gangarosa, A.M. Galazka, C.R. Wolfe, L.M. Philips, R.E. Gangarosa, and E. Miller Impact of anti-vaccine movements on pertussis control: the untold story Lancet 351 1998 356 361
40. D.S. Miller, M.J.H. Wadsworth, and E.M. Ross Pertussis vaccine and severe acute neurological illnesses. Response to a recent review by members of the NCES team Vaccine 7 1989 487 489
41. M. Kimura, and N. Hikino Results with a new DTP vaccine in Japan Dev Biol Stand 61 1985 545 561
42. J. Storsaeter, and P. Olin Relative efficacy of two acellular pertussis vaccines during three years of passive surveillance Vaccine 10 1992 142 144
43. WHO. Global Programme for Vaccine and Immunization, Expanded Programme on Immunization. Immunization policy. WHO/EPI/GEN/95.03.REV1, 1996.
44. M. Prijanto Penetapan standar nasional dari vaksin DPT. Penetapan standar nasional dari vaksin Pertussis Bull Health Studies Indonesia 10 1982 8 10
45. Sub Directorate of immunization, Indonesian CDC, Indonesian MOH. National Policy for immunization/Petunjuk Pelaksanaan Program Imunisasi, 3rd ed., 1993.
46. M.A. Fletcher, P. Saliou, C. Ethevanoux, and S.A. Plotkin The efficacy of whole-cell pertussis immunization: collected data on a vaccine produced in France Public Health 115 2 2001 119 129
47. Conseil superieur d'hygiene publique de France Calendrial vaccinal 1998 Bull Epidemiol Hebdomadaire 15 1999 61 62
48. M.D. Decker, and K. Edwards Combination vaccines S.A. Plotkin W.A. Orenstein Vaccine 3rd ed. 1999 WB Saunders Philadelphia 508 530
49. B.D. Gessner, A. Sutanto, M. Linehan, I.G. Djelantik, T. Fletcher, and I.K. Gerudug Incidences of vaccine- preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial Lancet 365 9453 2005 43 52